Ken Griffin Dyadic International Inc Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$1.52 - $2.04 $456 - $612	300 Added 23.08%	1,600 $2,000
Q3 2023 Nov 14, 2023	BUY	$1.71 - $2.08 $171 - $208	100 Added 8.33%	1,300 $2,000
Q2 2023 Aug 14, 2023	SELL	$1.56 - $2.38 $936 - $1,428	-600 Reduced 33.33%	1,200 $2,000
Q1 2023 May 15, 2023	BUY	$1.25 - $1.86 $500 - $744	400 Added 28.57%	1,800 $3,000
Q4 2022 Feb 14, 2023	BUY	$1.18 - $2.29 $1,652 - $3,206	1,400 New	1,400 $1,000

4.52M

1.2K

Ticker DYAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,423,100
Market Cap $44.1M
Description
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.